Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Brian VanScoy
Relationship Between Fosfomycin Exposure and Amplification of Escherichia Coli Subpopulations With Reduced Susceptibility in a Hollow-Fiber Infection Model
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
Determination of the Dynamically-Linked Indices of Fosfomycin for Pseudomonas Aeruginosa in the Hollow Fiber Infection Model (HFIM)
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Fosfomycin Inactivates Its Target Enzyme in Escherichia Coli Cells Carrying a Fosfomycin Resistance Plasmid.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Structure and Dynamics of FosA-mediated Fosfomycin Resistance in Klebsiella Pneumoniae and Escherichia Coli
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Neonatal Myeloid Derived Suppressor Cells Show Reduced Apoptosis and Immunosuppressive Activity Upon Infection With Escherichia Coli
European Journal of Immunology
Allergy
Immunology
Evaluation of Meropenem Regimens Suppressing Emergence of Resistance in Acinetobacter Baumannii With Human Simulated Exposure in an in Vitro Intravenous-Infusion Hollow-Fiber Infection Model
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Relationship Between Nasopharyngeal Microbiota and Patient’s Susceptibility to Viral Infection
Expert Review of Anti-Infective Therapy
Virology
Infectious Diseases
Microbiology
The Relationship Between Lay and Technical Views of Escherichia Coli O157 Risk
Philosophical Transactions of the Royal Society B: Biological Sciences
Biochemistry
Agricultural
Genetics
Molecular Biology
Biological Sciences
Evaluation of Once-Daily Vancomycin Against Methicillin-Resistant Staphylococcus Aureus in a Hollow-Fiber Infection Model
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Prevalence of Fosfomycin Resistance Among CTX-M-Producing Escherichia Coli Clinical Isolates in Japan and Identification of Novel Plasmid-Mediated Fosfomycin-Modifying Enzymes
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
